Electrospun β-TCP Bone Scaffold for Localized BMP-2 Retention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing bone graft materials that incorporate bone morphogenetic protein-2 (BMP-2) face issues with unintended leakage, leading to adverse effects such as inflammation and ectopic bone formation, as they do not effectively confine BMP-2 to the treatment site.
Innovation Solution
A bone regeneration material comprising biodegradable fibers with beta-tricalcium phosphate (β-TCP) and a targetable BMP-2 (tBMP-2) fusion protein, where BMP-2 is bound to β-TCP via a β-TCP-binding peptide, ensuring controlled release and confinement within the bone defect site.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If BMP-2 is incorporated into bone graft materials, then bone formation is promoted, but BMP-2 leaks to unintended sites causing adverse effects
Solution Approach 1:
The BMP-2 protein is nested within the three-dimensional porous structure of the calcium phosphate bone graft material. The peptide sequence of BMP-2 is embedded into the crystal lattice of hydroxyapatite or calcium phosphate, creating a hierarchical structure where the growth factor is contained within the material matrix at multiple levels, preventing leakage while maintaining biological activity
Solution Approach 2:
A peptide sequence acts as an intermediary between BMP-2 and the calcium phosphate material. This peptide sequence binds BMP-2 to the calcium phosphate crystal structure, serving as a molecular bridge that anchors the growth factor to the scaffold. The intermediary peptide allows controlled interaction between BMP-2 and the material while preventing uncontrolled release to surrounding tissues
2Productivity
If BMP-2 is released rapidly, then bone formation is accelerated, but unintended bone formation and inflammation occur
Solution Approach 1:
The calcium phosphate material provides periodic release of BMP-2 through its degradation pattern. As the calcium phosphate slowly degrades in the physiological environment, BMP-2 is released in a controlled periodic manner that matches the bone healing timeline, preventing sudden bursts of growth factor that could cause ectopic bone formation or inflammatory responses
Solution Approach 2:
BMP-2 is localized within the three-dimensional porous structure of the bone graft material at the specific defect site. The spatial distribution of BMP-2 throughout the porous scaffold ensures concentrated action at the intended location while the material's structure physically restricts diffusion to surrounding tissues, preventing ectopic bone formation
3Ease of operation
If the bone graft material has high porosity, then biological fluids permeate easily, but structural strength decreases
Solution Approach 1:
The bone graft material utilizes a three-dimensional porous structure made of calcium phosphate with controlled pore sizes and interconnectivity. This porous architecture allows biological fluids to permeate deeply throughout the material for nutrient transport and cell infiltration, while the calcium phosphate crystal structure and pore wall thickness are engineered to maintain sufficient mechanical strength for load-bearing applications
Solution Approach 2:
The bone graft material combines calcium phosphate with organic components and peptide sequences to create a composite structure. This composite approach allows optimization of both mechanical properties and biological functionality, where the inorganic calcium phosphate provides structural strength while the organic components and porous architecture enable fluid permeation and BMP-2 delivery
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The material ensures safe and controlled delivery of BMP-2, preventing leakage and minimizing adverse effects while promoting efficient bone regeneration by maintaining BMP-2 at the treatment site, facilitating continuous bone formation and remodeling.
Implementation Method 1
a spinning solution is ejected as a thin fiber from a nozzle and pulled by the electrostatic attraction in the electric field to be deposited on a collector
Implementation Method 2
BMP-2 is bound to the b-TCP via the b-TCP-binding peptide
Data Source
Figure 1A~1C
Figure 1D~1F
Figure 2~3
AI summary
A bone regeneration material has a cotton-wool like structure formed of a plurality of electrospun fibers that contain bound BMP-2 through β-TCP binding peptide. The electrospun biodegradable fiber contains 25-65 vol% of β-TCP particles distributed in the fiber such that a portion of the β-TCP particles is exposed on a surface of the electrospun fiber and the remaining portion of the β-TCP particles is buried in the fiber. β-TCP binding peptides that are fused with BMP-2 are bound to the β-TCP particles so that BMP-2 is tethered to β-TCP particles on the surface of the fibers. Upon implantation of the bone regeneration material in a bone defect site of a human body, BMP-2 that are tethered to β-TCP particles on the surface of the bone regeneration material promotes proliferation and differentiation of cells at the bone defect site.